快克品牌怎么样 申请店铺

我要投票 快克在医疗保健行业中的票数:842 更新时间:2025-08-06
快克是哪个国家的品牌?「快克」是 海南快克药业有限公司 旗下著名品牌。该品牌发源于海南省海口市,由创始人楼董在2002年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力快克品牌出海!将品牌入驻外推网,定制快克品牌推广信息,可以显著提高快克产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

快克怎么样

感冒药十大品牌,以快克感冒药和小快克感冒药著称,以经营和批发中西药制剂/原料药为主,集医药生产、经营、科研为一体的综合性集团


海南快克药业有限公司创建于2002年9月23日,由海南亚洲制药股份有限公司投资设立,公司总部设在海南省海口市,公司注册总资本500万元,员工近800人,以经营和批发中西药制剂,原料药为主。

公司始终秉承控股公司“供给好药、服务社会“的理念,以优质的产品和责任回报社会,主要承担控股公司下属企业生产的药品销售和品牌的经营。

2004年“小快克”以科学的处方,合理的剂型,良好的口感正式上市并深受消费者认可;

2007年,由中国疾病预防控制中心健康教育所主办的“防治流感•中国行动”公益健康科教活动在北京人民大会堂隆重启动;

2009年,兄弟公司生产的止咳药“快克露”成功上市;

2012年,快克品牌又添“快克泰”、“快克清”、“快克西林”等新成员,同年毒胶囊事件“快克”胶囊铬批批检验合格,是消费者可放心服用的安全胶囊,同时向全社会发布《快克品牌产品供应链透明化-白皮书》。

2014年,公司一次性通过新版GSP认证;同年为响应全民健身的国家战略,发起亲子Cool跑的健康公益活动,倡导健康、快乐,合理用药的生活方式。

展望未来,前进中的海南快克药业有限公司继续坚持“诚、勤、学”的“3S”精神,引导和鼓励着员工追求卓越,吸引更多的优秀人才加入团队,我们将一直践行公司的理念和使命,不忘回报社会,供给好药竭诚为全人类的健康服务。


Hainan quick Pharmaceutical Co., Ltd., a comprehensive group integrating pharmaceutical production, management and scientific research, was founded on September 23, 2002, invested and established by Hainan Yazhou Pharmaceutical Co., Ltd. with its headquarters in Haikou City, Hainan Province. It is famous for quick cold medicine and small quick cold medicine. It is mainly engaged in the management and wholesale of Chinese and Western pharmaceutical preparations / APIs. The company is registered With a total capital of 5 million yuan and nearly 800 employees, it mainly manages and wholesales Chinese and Western medicine preparations and APIs. The company always adheres to the concept of "providing good medicine and serving the society" of the holding company, returns to the society with high-quality products and responsibilities, and mainly undertakes the drug sales and brand management of the subordinate enterprises of the holding company. In 2004, "xiaokuai Ke" was officially listed with scientific prescription, reasonable dosage form and good taste and was recognized by consumers; in 2007, the public health science and education activity of "prevention and control of influenza · China action" sponsored by Health Education Institute of China Center for Disease Control and prevention was grandly launched in the Great Hall of the people in Beijing; in 2009, the cough medicine "Kuai Ke Lu" produced by brother company was successfully listed; 2 In 012, new members such as "klystron", "klystron", "klystron" and "klystron" were added to klystron brand. In the same year, the chromium batch inspection of "klystron" capsule was qualified. It was a safe capsule for consumers to take at ease. Meanwhile, the "transparency of supply chain of klystron brand products - white paper" was released to the whole society. In 2014, the company passed the new GSP certification at one time; in the same year, in response to the national strategy of national fitness, the company launched the health public welfare activities of parent-child cool run, and advocated a healthy, happy and rational drug use lifestyle. Looking forward to the future, Hainan quick Pharmaceutical Co., Ltd. will continue to adhere to the "3S" spirit of "sincerity, diligence and learning", guide and encourage employees to pursue excellence and attract more excellent talents to join the team. We will always practice the company's concept and mission, never forget to repay the society, and provide good medicine to serve the health of the whole mankind wholeheartedly.

本文链接: https://brand.waitui.com/0c32f4950.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

Palantir季度营收首破10亿美元大关,上调2025全年业绩指引

数据挖掘公司Palantir在人工智能热潮中再创佳绩:季度营收首次突破10亿美元大关,同比激增48%至10亿美元;调整后每股收益0.16美元,两项数据均超市场预期。公司同时将2025全年营收预期上调至41.42-41.50亿美元,显著高于此前指引。(新浪财经)

53分钟前

特朗普:将在未来24小时内大幅提高印度关税

据报道,美国总统特朗普表示,将在未来24小时内大幅提高印度关税。(界面)

53分钟前

美股大型科技股盘前多数上涨,亚马逊涨0.67%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,亚马逊涨0.67%,微软涨0.54%,英伟达涨0.37%,特斯拉涨0.23%,苹果涨0.21%,奈飞涨0.16%,谷歌涨0.14%;Meta跌0.05%。

53分钟前

热门中概股美股盘前多数上涨,哔哩哔哩涨超3%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,哔哩哔哩涨超3%,理想汽车涨超2%,蔚来、网易、富途控股、腾讯音乐涨超1%,小鹏汽车涨近1%;京东跌0.73%,百度跌0.43%。

54分钟前

石药集团:司美格鲁肽注射液上市申请获国家药监局受理

36氪获悉,石药集团发布公告,附属公司石药集团百克(山东)生物制药股份有限公司开发的司美格鲁肽注射液的上市申请已获国家药品监督管理局受理。本次申报的适应症为成人2型糖尿病患者的血糖控制。

54分钟前

本页详细列出关于快克的品牌信息,含品牌所属公司介绍,快克所处行业的品牌地位及优势。
咨询